News & Events

News

5th Annual Tufts-CEVR’s Cost-Effectiveness Analysis Paper of the Year Award Winner
5th Annual Tufts-CEVR’s Cost-Effectiveness Analysis Paper of the Year Award Winner Center for the Evaluation of Value and Risk in Health (CEVR) at T...
Read more April 25, 2023
New CEVR publication: Cost-effectiveness thresholds used by study authors, 1990-2021
Journal: Journal of the American Medical Association Citation: Neumann PJ, Kim DD. Cost-effectiveness Thresholds Used by Study Authors, 1990-2021. JA...
Read more April 18, 2023
CEVR Remembers Philanthropist Gordon Moore
CEVR Remembers Philanthropist Gordon Moore The Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center mourns the passin...
Read more March 28, 2023
View All News Items

Events

Health Policy Seminar with Victoria Fan, ScD
Learn more
12:30 on June 5, 2023
Seminar with Brian D Smith, BSc, DipM PhD FRSA
Learn more
12:00–1:00 on December 1, 2022
Health Policy Seminar with Hadley Stevens Smith, PhD, MPSA
Learn more
12:00–1:00 on November 16, 2022
View All Events

Publications

Journal of Managed Care and Specialty Pharmacy
Specialty drug coverage varies between health plans’ medical and pharmacy benefit policies
View publication
Journal of the American Medical Association
Cost-effectiveness thresholds used by study authors, 1990-2021
View publication
Value in Health
Developing Criteria for Health Economic Quality Evaluation Tool
View publication
BioDrugs
Factors Associated with Biosimilar Exclusions and Step Therapy Restrictions Among US Commercial Health Plans
View publication
Health Policy OPEN
The impact of external reference pricing on pharmaceutical costs and market dynamics
View publication
Journal of Managed Care + Specialty Pharmacy
The association between US Food and Drug Administration−expedited review designations and health plan specialty drug coverage
View publication
STAT News First Opinion
The much-maligned ‘quality-adjusted life year’ is a vital tool for health care policy
View publication
Journal of Managed Care + Specialty Pharmacy
Commercial health plans use of patient subgroup restrictions: An analysis of orphan and FDA-expedited programs
View publication
Alzheimer's & Dementia
Variation in Medicaid and commercial payer coverage of aducanumab for Alzheimer's disease
View publication
View All Publications